For the first time, medications are available that can help type 2 diabetes patients control their glucose and help reduce their cardiovascular event risk. Drs. Doron Schneider and Bernard Zinman explore how to incorporate them into patient care.
You are here
The Endocrine Society's Guidelines for the Pharmacologic Management of Obesity, advises clinicians to "treat weight first" to mitigate or eliminate its related comorbidities and complications including type 2 diabetes. Learn more about this dynamic program, the benefits of weight reduction on diabetes, and how to earn 1.5 AMA PRA Category 1 CME credits.
Dr. Doron Schneider and Dr. Jack Leahy discuss what The Diabetes Control and Complications discovered about weight issues and the Diabetic patient.
Dr. Doron Schneider and Dr. Jack Leahy discuss what the DCCT and EDIC trials found regarding type 2 diabetes.
Dr. Schneider and Dr. Leahy discuss the surprising result of "metabolic memory" from the findings of the DCCT and EDIC trials.
Dr. Schneider and Dr. Leahy, discuss the findings of the DCCT and EDIC studies as they relate to the impact of tight control of diabetes in the early stages of the disease.
Dr. Schneider and Dr. Leahy discuss EDIC, the follow up study to The Diabetes Control and Complications trial.
Dr. Doron Schneider and Dr. Jack Leahy discuss The Diabetes and Complications Trial, a landmark study that still influences the standard of diabetes patient care.
Dr. Doron Schneider and Dr. Jack Leahy discuss the Diabetes Control and Complications Trial and the follow up study, EDIC. These landmark, studies performed 30 years ago, have stood the test of time and still influences the standard of care today.
Obstructive sleep apnea is a common and underdiagnosed condition in patients with type 2 diabetes. This blog post explores what is known about the underlying mechanism that may relate sleep apnea to diabetes.